Alx Oncology Holdings (ALXO) Other financing activities (2021 - 2026)

Alx Oncology Holdings (ALXO) has 6 years of Other financing activities data on file, last reported at $3000.0 in Q1 2026.

• For the quarter ending Q1 2026, Other financing activities changed N/A year-over-year to $3000.0; the trailing twelve-month figure through Mar 2026 stood at $12000.0 (changed N/A YoY), and the FY2025 full-year result was $24000.0, down 98.53% from the prior year.
• Other financing activities eased to $3000.0 in Q1 2026, from $23000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $1.3 million in Q3 2024 to a low of -$38000.0 in Q3 2022.
• A 5-year average of $194272.7 and a median of $69000.0 in 2024 frame the typical range for Other financing activities.
• Across the five-year window, Other financing activities plunged 107.0% in 2022 and jumped 361.76% in 2023, its largest moves.
• Tracing ALXO's Other financing activities over 5 years: stood at $34000.0 in 2022, then jumped by 361.76% to $157000.0 in 2023, then jumped by 744.59% to $1.3 million in 2024, then tumbled by 98.27% to $23000.0 in 2025, then plunged by 86.96% to $3000.0 in 2026.
• Business Quant data shows ALXO's Other financing activities at $3000.0 in Q1 2026, $23000.0 in Q4 2025, and -$14000.0 in Q3 2025.